Respiratory News and Research

RSS

Study highlights gender inequality in lung transplantation access and outcomes

Women are less likely to receive a lung transplant and spend an average of six weeks longer on the waiting list, according to a study published today (Thursday) in ERJ Open Research.

8 Jan 2025

Age-related decline in cardiac conduction system regeneration increases arrhythmia risk after heart attack

Study uncovers the impact of myocardial infarction on the cardiac conduction system, revealing insights into arrhythmogenesis and potential therapeutic targets.

8 Jan 2025

Extended Paxlovid courses show mixed results for long COVID symptoms

A study indicates that longer Paxlovid treatments could improve long COVID symptoms in some patients, highlighting the need for tailored antiviral strategies.

8 Jan 2025

Researchers uncover diverse asthma endotypes in youths using nasal transcriptomics

The study highlights T2-low and T17-high asthma endotypes in minoritized youths, offering insights for precision medicine and improved asthma management.

7 Jan 2025

Hidden culprit: Human metapneumovirus identified in severe adult pneumonia case

Severe pneumonia caused by human metapneumovirus in an immunocompetent adult highlights diagnostic challenges and underscores the need for rapid molecular diagnostics to improve outcomes.

6 Jan 2025

Novel hMPV strains linked to rising respiratory infections in young children

Researchers in India discovered novel hMPV lineages A2.2.1 and A2.2.2, emphasizing their role in pediatric respiratory infections and potential public health implications.

6 Jan 2025

Extended course of Paxlovid shows promise for some long Covid patients

An up-close look at how patients respond to the drug at different times and doses adds nuance to a recent finding that Paxlovid does not work for long Covid.

6 Jan 2025

Inogen receives FDA 510(k) clearance for SIMEOX 200 airway clearance device

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SIMEOX 200 Airway Clearance Device, expanding the company’s ability to market and meet the various needs of patients with chronic respiratory diseases in the U.S.

6 Jan 2025

Study finds no clinical advantage of budesonide inhaler over fluticasone in COPD

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD exacerbations and pneumonia risk.

6 Jan 2025

H5N1 bird flu spillover to horses, raises fears of new viral strains

Researchers report the first confirmed cases of H5N1 bird flu in horses, highlighting their role as potential reservoirs for viral reassortment. This groundbreaking study urges increased surveillance to prevent novel influenza epidemics.

5 Jan 2025

Study highlights the importance of diagnostic tests in pandemic response

The COVID-19 pandemic highlighted how crucial testing is for disease preparedness and response, and new research from the Johns Hopkins Applied Physics Laboratory (APL) and a team of collaborators underscores that principle.

3 Jan 2025

Switching to e-cigarettes may ease respiratory symptoms, offering hope for smokers

The study indicates that e-cigarettes might reduce smoking-related respiratory symptoms, yet further research is essential to understand long-term effects.

3 Jan 2025

Mild avian flu cases in US spark safety warnings for poultry and dairy sectors

Researchers identify 46 mild cases of avian influenza A(H5N1) in U.S. poultry and dairy workers, highlighting low PPE adherence and potential outbreak risks.

2 Jan 2025

CDC study highlights growing tularemia threat in central U.S.

Tularemia cases in the U.S. rose by 56% from 2011 to 2022, with central states and American Indian communities most affected, highlighting diagnostic advancements and health disparities.

2 Jan 2025

Breakthrough in immunology: AbMAP’s novel approach to antibody modeling

Researchers developed AbMAP, a cutting-edge framework leveraging transfer learning to model antibody hypervariable regions, significantly improving design and immune repertoire analysis.

2 Jan 2025

Public health experts outline critical steps in handling HPAI H5N1 spread

Highly pathogenic H5N1 avian influenza A virus (HPAI H5N1) remains a low risk to the general public, and public health experts in the United States believe that available treatments and vaccines, as well as those in development, are sufficient to prevent severe disease.

2 Jan 2025

Physical activity linked to lower risk of having chronic conditions

University of Iowa researchers are recommending all patients be surveyed about their physical activity levels, after a new study underscores the link between physical activity and chronic disease.

2 Jan 2025

Scientists pinpoint regions and species fueling coronavirus evolution in bats

Study uncovers the evolution, transmission, and geographic spread of bat coronaviruses in China, revealing key insights into hotspots and the origins of SARS-CoV-2.

1 Jan 2025

Immunocompromised adults show weaker response to RSV vaccines

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity - primarily organ transplant recipients who take immunosuppressive medications to reduce the risk of rejection and others with immune system disorders - do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with normal immune function.

30 Dec 2024

Study reveals role of kidneys in high altitude acclimatization

A study from a Mount Royal University physiologist and his team demonstrates the key role of the kidneys in acclimatization to high altitude, and illustrates another way that Sherpas are better adapted to high altitude ascent.

30 Dec 2024